MX9300406A - Derivados azabiciclicos procedimientos para su preparacion y composiciones que los contienen. - Google Patents
Derivados azabiciclicos procedimientos para su preparacion y composiciones que los contienen.Info
- Publication number
- MX9300406A MX9300406A MX9300406A MX9300406A MX9300406A MX 9300406 A MX9300406 A MX 9300406A MX 9300406 A MX9300406 A MX 9300406A MX 9300406 A MX9300406 A MX 9300406A MX 9300406 A MX9300406 A MX 9300406A
- Authority
- MX
- Mexico
- Prior art keywords
- derivatives
- preparation
- azabiciclic
- procedures
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929201751A GB9201751D0 (en) | 1992-01-28 | 1992-01-28 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9300406A true MX9300406A (es) | 1994-07-29 |
Family
ID=10709351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9300406A MX9300406A (es) | 1992-01-28 | 1993-01-26 | Derivados azabiciclicos procedimientos para su preparacion y composiciones que los contienen. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0625981A1 (de) |
| JP (1) | JPH07503462A (de) |
| KR (1) | KR950700305A (de) |
| AU (1) | AU3364593A (de) |
| CA (1) | CA2128536A1 (de) |
| GB (1) | GB9201751D0 (de) |
| MX (1) | MX9300406A (de) |
| WO (1) | WO1993015080A1 (de) |
| ZA (1) | ZA93549B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9314973D0 (en) * | 1993-07-20 | 1993-09-01 | Smithkline Beecham Plc | Medicaments |
| UY25225A1 (es) | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | Derivados de pleuromutilina utiles como agentes antimicrobianos |
| AU1600599A (en) | 1998-02-27 | 1999-09-15 | Warner-Lambert Company | Heterocyclic substituted aniline calcium channel blockers |
| US6166052A (en) * | 1998-03-11 | 2000-12-26 | Warner-Lambert Company | Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers |
| CA2441896A1 (en) | 2000-12-22 | 2002-07-04 | Almirall Prodesfarma Ag | Quinuclidine carbamate derivatives and their use as m3 antagonists |
| ES2203327B1 (es) | 2002-06-21 | 2005-06-16 | Almirall Prodesfarma, S.A. | Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen. |
| ES2204295B1 (es) | 2002-07-02 | 2005-08-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de quinuclidina-amida. |
| WO2009046025A1 (en) | 2007-10-01 | 2009-04-09 | Comentis, Inc. | Quinuclidin-4-ylmethyl 1h-indole-3-carboxylate derivatives as alpha 7 nicotinic acetylcholine receptor ligands for the treatment of alzheimer's disease |
| WO2016007630A1 (en) | 2014-07-11 | 2016-01-14 | Alpharmagen, Llc | Quinuclidine compounds for modulating alpha7 -nicotinic acetylcholine receptor activity |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1250534A (de) * | 1969-03-03 | 1971-10-20 | ||
| GB9005737D0 (en) * | 1990-03-14 | 1990-05-09 | Beecham Group Plc | Novel compounds |
-
1992
- 1992-01-28 GB GB929201751A patent/GB9201751D0/en active Pending
-
1993
- 1993-01-26 MX MX9300406A patent/MX9300406A/es unknown
- 1993-01-26 ZA ZA93549A patent/ZA93549B/xx unknown
- 1993-01-27 CA CA002128536A patent/CA2128536A1/en not_active Abandoned
- 1993-01-27 WO PCT/GB1993/000174 patent/WO1993015080A1/en not_active Application Discontinuation
- 1993-01-27 AU AU33645/93A patent/AU3364593A/en not_active Abandoned
- 1993-01-27 EP EP93902470A patent/EP0625981A1/de not_active Withdrawn
- 1993-01-27 JP JP5513048A patent/JPH07503462A/ja active Pending
-
1994
- 1994-07-27 KR KR1019940702589A patent/KR950700305A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR950700305A (ko) | 1995-01-16 |
| CA2128536A1 (en) | 1993-08-05 |
| AU3364593A (en) | 1993-09-01 |
| WO1993015080A1 (en) | 1993-08-05 |
| EP0625981A1 (de) | 1994-11-30 |
| ZA93549B (en) | 1994-09-22 |
| GB9201751D0 (en) | 1992-03-11 |
| JPH07503462A (ja) | 1995-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9300407A (es) | Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion. | |
| AR005703A1 (es) | Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen | |
| GT199900102A (es) | Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen. | |
| ES2144192T3 (es) | Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| AR020019A1 (es) | Composicion farmaceutica para la prevencion o el tratamiento de cancer de mama | |
| IT1170286B (it) | Derivati del labdano, procedimento per la loro preparazione, e composizioni farmaceutiche contenenti derivati del labdano | |
| MX9400166A (es) | Microesferas de proteina vegetal, hidrolizada, modificada y metodos para su preparacion y su uso. | |
| PA8479201A1 (es) | Derivados del acido hidroxi-pipecolato hidroxamico | |
| ES2052603T3 (es) | Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen. | |
| ES2018478B3 (es) | Un sistema para preparar una composicion desensibilizante dental. | |
| AR008991A1 (es) | Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimientos para su preparacion y aplicacion de los mismos | |
| BR9608488A (pt) | Uso de derivados da vitamina d4 no tratamento de câncer | |
| ES2061688T3 (es) | Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion. | |
| IL64292A0 (en) | D-homosteroids,their manufacture and pharmaceutical compositions containing them | |
| MX9202152A (es) | Derivados del indol, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| MX9304793A (es) | Glicanas de actividad inmunoestimulante. | |
| MX9300406A (es) | Derivados azabiciclicos procedimientos para su preparacion y composiciones que los contienen. | |
| MX9303572A (es) | Inhibidores de proteasa del sindrome de inmunodeficiencia humana, procedimiento para su preparacion y formualcion farmaceutica que los contiene. | |
| MX9301157A (es) | Derivados de bencimidazolona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| AR002017A1 (es) | Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento. | |
| ES2127263T3 (es) | Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| ES2052484T1 (es) | N-(5-tioxo-l-prolil)-l-cisteina, sus derivados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
| MX9307203A (es) | COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS. | |
| IT8248970A0 (it) | Derivati xantinici, procedimento per la loro preparazione, composizione farmaceutiche che li contengono e loro impiego terapeutico | |
| ES2175661T3 (es) | Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen. |